Skip to main content

Management of Infections in Neutropenic Patients

  • Chapter
  • First Online:
Benign Hematologic Disorders in Children
  • 674 Accesses

Abstract

Neutropenia is a decrease in the circulating pool of neutrophils. This may be secondary to margination, increased consumption following bacterial infection, antibody-mediated destruction, and bone marrow suppression due to viral infections, medications, or chemotherapy. The host with severe neutropenia is at risk of bacterial and fungal disease. In severe neutropenia, the inflammatory response is muted and, therefore, fever in a neutropenic host could be a sign of serious infection. Febrile neutropenia in children is a heterogeneous entity with potential for severe outcomes, and management of these children is based on clinical judgment in conjunction with physical and laboratory findings.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. MC D, PE N. The phagocyte system and disorders of granulopoiesis and granulocyte function. 7th ed. DG OSN, D G, AT L, D F, SE L, editors. Philadelphia, PA: Saunders Elsevier; 2009.

    Google Scholar 

  2. American Academy of Allergy AI. Neutropenia [Available from: https://www.aaaai.org/conditions-and-treatments/conditions-dictionary/neutropenia.

  3. PR D. Neutropenia. 16th ed. AM R, editor. New York, NY: Appleton-Century-Crofts; 1977.

    Google Scholar 

  4. Segel GB, Halterman JS. Neutropenia in pediatric practice. Pediatr Rev. 2008;29(1):12–23. quiz 4

    Article  PubMed  Google Scholar 

  5. Denic S, Narchi H, Al Mekaini LA, Al-Hammadi S, Al Jabri ON, Souid AK. Prevalence of neutropenia in children by nationality. BMC Hematol. 2016;16:15.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the management of fever and neutropenia in children with cancer and hematopoietic stem-cell transplantation recipients: 2017 update. J Clin Oncol. 2017;35(18):2082–94.

    Article  CAS  PubMed  Google Scholar 

  7. Asano Y, Yoshikawa T, Suga S, Kobayashi I, Nakashima T, Yazaki T, et al. Clinical features of infants with primary human herpesvirus 6 infection (exanthem subitum, roseola infantum). Pediatrics. 1994;93(1):104–8.

    Article  CAS  PubMed  Google Scholar 

  8. Stevens DL, Everett ED, Boxer LA, Landefeld RA. Infectious mononucleosis with severe neutropenia and opsonic antineutrophil activity. South Med J. 1979;72(5):519–21.

    Article  CAS  PubMed  Google Scholar 

  9. Roullet E, Bleichner G, Mathiot C, Varet B, Monsallier JF. [Acute neutropenia in adult severe bacterial infections. Six cases (author's transl)]. Ann Med Interne (Paris). 1981;132(8):554–8.

    Google Scholar 

  10. Bonadio WA, Stremski E, Shallow K. Clinical characteristics of children with fever and transient neutropenia who experience serious bacterial infections. Pediatr Emerg Care. 1989;5(3):163–5.

    Article  CAS  PubMed  Google Scholar 

  11. Husain EH, Mullah-Ali A, Al-Sharidah S, Azab AF, Adekile A. Infectious etiologies of transient neutropenia in previously healthy children. Pediatr Infect Dis J. 2012;31(6):575–7.

    Article  PubMed  Google Scholar 

  12. Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med. 1966;64(2):328–40.

    Article  CAS  PubMed  Google Scholar 

  13. Petrilli AS, Melaragno R, Barros KV, Silva AA, Kusano E, Ribeiro RC, et al. Fever and neutropenia in children with cancer: a therapeutic approach related to the underlying disease. Pediatr Infect Dis J. 1993;12(11):916–21.

    Article  CAS  PubMed  Google Scholar 

  14. Castagnola E, Fontana V, Caviglia I, Caruso S, Faraci M, Fioredda F, et al. A prospective study on the epidemiology of febrile episodes during chemotherapy-induced neutropenia in children with cancer or after hemopoietic stem cell transplantation. Clin Infect Dis. 2007;45(10):1296–304.

    Article  PubMed  Google Scholar 

  15. R B, TL H, WE H. NEUTROPENIA IN THE PEDIATRIC POPULATION AND ITS ASSOCIATION WITH INFECTION. 1984. p. 236.

    Google Scholar 

  16. Jonsson OG, Buchanan GR. Chronic neutropenia during childhood. A 13-year experience in a single institution. Am J Dis Child. 1991;145(2):232–5.

    Article  CAS  PubMed  Google Scholar 

  17. Valiaveedan R, Rao S, Miller S, Brown A. Transient neutropenia of childhood. Clin Pediatr (Phila). 1987;26(12):639–42.

    Article  CAS  Google Scholar 

  18. Serwint JR, Dias MM, Chang H, Sharkey M, Walker AR. Outcomes of febrile children presumed to be immunocompetent who present with leukopenia or neutropenia to an ambulatory setting. Clin Pediatr (Phila). 2005;44(7):593–600.

    Article  CAS  Google Scholar 

  19. Melendez E, Harper MB. Risk of serious bacterial infection in isolated and unsuspected neutropenia. Acad Emerg Med. 2010;17(2):163–7.

    Article  PubMed  Google Scholar 

  20. Karavanaki K, Polychronopoulou S, Giannaki M, Haliotis F, Sider B, Brisimitzi M, et al. Transient and chronic neutropenias detected in children with different viral and bacterial infections. Acta Paediatr. 2006;95(5):565–72.

    Article  PubMed  Google Scholar 

  21. Alexandropoulou O, Kossiva L, Haliotis F, Giannaki M, Tsolia M, Panagiotou IP, et al. Transient neutropenia in children with febrile illness and associated infectious agents: 2 years' follow-up. Eur J Pediatr. 2013;172(6):811–9.

    Article  PubMed  Google Scholar 

  22. Vlacha V, Feketea G. The clinical significance of non-malignant neutropenia in hospitalized children. Ann Hematol. 2007;86(12):865–70.

    Article  PubMed  Google Scholar 

  23. Sheen JM, Kuo HC, Yu HR, Huang EY, Wu CC, Yang KD. Prolonged acquired neutropenia in children. Pediatr Blood Cancer. 2009;53(7):1284–8.

    Article  PubMed  Google Scholar 

  24. Bux J, Behrens G, Jaeger G, Welte K. Diagnosis and clinical course of autoimmune neutropenia in infancy: analysis of 240 cases. Blood. 1998;91(1):181–6.

    Article  CAS  PubMed  Google Scholar 

  25. Teachey DT, Lambert MP. Diagnosis and management of autoimmune cytopenias in childhood. Pediatr Clin N Am. 2013;60(6):1489–511.

    Article  Google Scholar 

  26. Kirk SE, Grimes AB, Shelke S, Despotovic JM, Powers JM. The cost of a "benign" condition: healthcare utilization and infectious outcomes in young children with primary autoimmune neutropenia. Pediatr Blood Cancer. 2019:e28146.

    Google Scholar 

  27. Raad I, Hachem R, Hanna H, Bahna P, Chatzinikolaou I, Fang X, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007;26(8):549–56.

    Article  CAS  PubMed  Google Scholar 

  28. Paul M, Gafter-Gvili A, Leibovici L, Bishara J, Levy I, Yaniv I, et al. The epidemiology of bacteremia with febrile neutropenia: experience from a single center, 1988-2004. Isr Med Assoc J. 2007;9(6):424–9.

    PubMed  Google Scholar 

  29. Pizzo PA, Robichaud KJ, Gill FA, Witebsky FG. Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia. Am J Med. 1982;72(1):101–11.

    Article  CAS  PubMed  Google Scholar 

  30. Barg AA, Kozer E, Mordish Y, Lazarovitch T, Kventsel I, Goldman M. The risk of serious bacterial infection in neutropenic immunocompetent febrile children. J Pediatr Hematol Oncol. 2015;37(6):e347–51.

    Article  PubMed  Google Scholar 

  31. Alario AJ. Management of the febrile, otherwise healthy child with neutropenia. Pediatr Infect Dis J. 1994;13(2):169–70.

    Article  CAS  PubMed  Google Scholar 

  32. Handrup MM, Møller JK, Rutkjaer C, Schrøder H. Importance of blood cultures from peripheral veins in pediatric patients with cancer and a central venous line. Pediatr Blood Cancer. 2015;62(1):99–102.

    Article  PubMed  Google Scholar 

  33. Scheinemann K, Ethier MC, Dupuis LL, Richardson SE, Doyle J, Allen U, et al. Utility of peripheral blood cultures in bacteremic pediatric cancer patients with a central line. Support Care Cancer. 2010;18(8):913–9.

    Article  PubMed  Google Scholar 

  34. Klaassen IL, de Haas V, van Wijk JA, Kaspers GJ, Bijlsma M, Bökenkamp A. Pyuria is absent during urinary tract infections in neutropenic patients. Pediatr Blood Cancer. 2011;56(5):868–70.

    Article  CAS  PubMed  Google Scholar 

  35. Mori R, Yonemoto N, Fitzgerald A, Tullus K, Verrier-Jones K, Lakhanpaul M. Diagnostic performance of urine dipstick testing in children with suspected UTI: a systematic review of relationship with age and comparison with microscopy. Acta Paediatr. 2010;99(4):581–4.

    Article  CAS  PubMed  Google Scholar 

  36. Sandoval C, Sinaki B, Weiss R, Munoz J, Ozkaynak MF, Tugal O, et al. Urinary tract infections in pediatric oncology patients with fever and neutropenia. Pediatr Hematol Oncol. 2012;29(1):68–72.

    Article  PubMed  Google Scholar 

  37. Phillips RS, Lehrnbecher T, Alexander S, Sung L. Updated systematic review and meta-analysis of the performance of risk prediction rules in children and young people with febrile neutropenia. PLoS One. 2012;7(5):e38300.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Roberts SD, Wells GM, Gandhi NM, York NR, Maron G, Razzouk B, et al. Diagnostic value of routine chest radiography in febrile, neutropenic children for early detection of pneumonia and mould infections. Support Care Cancer. 2012;20(10):2589–94.

    Article  PubMed  Google Scholar 

  39. Aamir M, Abrol P, Sharma D, Punia H. A clinical evaluation of efficacy and safety of cefepime monotherapy versus piperacillin-tazobactam in patients of paediatric age group with febrile neutropenia in a tertiary care centre of north India. Trop Dr. 2016;46(3):142–8.

    Google Scholar 

  40. Sano H, Kobayashi R, Suzuki D, Kishimoto K, Yasuda K, Kobayashi K. Comparison between piperacillin/tazobactam and cefepime monotherapies as an empirical therapy for febrile neutropenia in children with hematological and malignant disorders: a prospective, randomized study. Pediatr Blood Cancer. 2015;62(2):356–8.

    Article  CAS  PubMed  Google Scholar 

  41. Robinson PD, Lehrnbecher T, Phillips R, Dupuis LL, Sung L. Strategies for empiric management of pediatric fever and neutropenia in patients with cancer and hematopoietic stem-cell transplantation recipients: a systematic review of randomized trials. J Clin Oncol. 2016;34(17):2054–60.

    Article  CAS  PubMed  Google Scholar 

  42. Vardakas KZ, Samonis G, Chrysanthopoulou SA, Bliziotis IA, Falagas ME. Role of glycopeptides as part of initial empirical treatment of febrile neutropenic patients: a meta-analysis of randomised controlled trials. Lancet Infect Dis. 2005;5(7):431–9.

    Article  CAS  PubMed  Google Scholar 

  43. Griffin TC, Buchanan GR. Hematologic predictors of bone marrow recovery in neutropenic patients hospitalized for fever: implications for discontinuation of antibiotics and early discharge from the hospital. J Pediatr. 1992;121(1):28–33.

    Article  CAS  PubMed  Google Scholar 

  44. Raad I, Hanna H, Osting C, Hachem R, Umphrey J, Tarrand J, et al. Masking of neutropenic patients on transport from hospital rooms is associated with a decrease in nosocomial aspergillosis during construction. Infect Control Hosp Epidemiol. 2002;23(1):41–3.

    Article  PubMed  Google Scholar 

  45. CDC IfDSoA, and the American Society of Blood and Marrow Transplantation. Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients. Recommendations of CDC, the Infectious Disease Society of America, and the American Society of Blood and Marrow Transplantation. Cytotherapy. 2001;3(1):41–54.

    Article  Google Scholar 

  46. Robinson CL, Bernstein H, Romero JR, Szilagyi P. Advisory committee on immunization practices recommended immunization schedule for children and adolescents aged 18 years or younger – United States, 2019. MMWR Morb Mortal Wkly Rep. 2019;68(5):112–4.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–318.

    Google Scholar 

  48. Moody K, Finlay J, Mancuso C, Charlson M. Feasibility and safety of a pilot randomized trial of infection rate: neutropenic diet versus standard food safety guidelines. J Pediatr Hematol Oncol. 2006;28(3):126–33.

    Article  PubMed  Google Scholar 

  49. Moody KM, Baker RA, Santizo RO, Olmez I, Spies JM, Buthmann A, et al. A randomized trial of the effectiveness of the neutropenic diet versus food safety guidelines on infection rate in pediatric oncology patients. Pediatr Blood Cancer. 2018;65(1)

    Google Scholar 

  50. Tramsen L, Salzmann-Manrique E, Bochennek K, Klingebiel T, Reinhardt D, Creutzig U, et al. Lack of effectiveness of neutropenic diet and social restrictions as anti-infective measures in children with acute myeloid leukemia: an analysis of the AML-BFM 2004 trial. J Clin Oncol. 2016;34(23):2776–83.

    Article  PubMed  PubMed Central  Google Scholar 

  51. Safe Food Handling: What You Need to Know. [Available from: https://www.fda.gov/Food/FoodborneIllnessContaminants/BuyStoreServeSafeFood/ucm255180.htm.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Shipra Gupta .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Gupta, S. (2021). Management of Infections in Neutropenic Patients. In: Kamat, D., Frei-Jones, M. (eds) Benign Hematologic Disorders in Children. Springer, Cham. https://doi.org/10.1007/978-3-030-49980-8_30

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-49980-8_30

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-49979-2

  • Online ISBN: 978-3-030-49980-8

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics